Amplification of the <i>MYC</i> gene in immunoglobulin light chain (AL) amyloidosis-Reference-Cited by-同舟云学术

Amplification of the MYC gene in immunoglobulin light chain (AL) amyloidosis

Published:2019-12-25 Issue:2 Volume:22 Page:54-62
ISSN:1344-1817
Container-title:Tenri Medical Bulletin
language:en
Short-container-title:Tenri Med Bull

Author:

Toda Yusuke¹²,Tagawa Shunsuke³,Takeoka Kayo⁴,Kishimori Chiyuki⁴,Hayashida Masahiko⁴,Iioka Futoshi¹,Honjo Gen⁵,Ohno Hitoshi¹⁴

Affiliation:

1. Department of Hematology, Tenri Hospital

2. Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University

3. Department of Cardiology, Tenri Hospital

4. Tenri Institute of Medical Research

5. Department of Diagnostic Pathology, Tenri Hospital

Publisher

Tenri Foundation, Tenri Institute of Medical Research

Link

https://www.jstage.jst.go.jp/article/tenrikiyo/22/2/22_22-013/_pdf

Reference18 articles.

1. 1 Rajikumar SV, Dispenzier A. Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis. In: Glassock RJ, Kyle RA, Connor RF, eds. UpToDate; 2019.

2. 2 McKenna RW, Kyle RA, Kuehl WM, et al. Plasma cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition). Lyon: IARC; 2017:241-258.

3. 3 Nilsson T, Lenhoff S, Rylander L, et al. High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation. Br J Haematol 2004;126:487-494.

4. 4 Boyd KD, Ross FM, Chiecchio L, et al. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: Analysis of patients treated in the MRC Myeloma IX trial. Leukemia 2012;26:349-355.

5. 5 Fonseca R, Bergsagel PL, Drach J, et al. International Myeloma Working Group molecular classification of multiple myeloma: Spotlight review. Leukemia 2009;23:2210-2221.